ID

18794

Descripción

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa; ODM derived from: https://clinicaltrials.gov/show/NCT00381472

Link

https://clinicaltrials.gov/show/NCT00381472

Palabras clave

  1. 21/11/16 21/11/16 -
Subido en

21 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Parkinson Disease NCT00381472

Eligibility Parkinson Disease NCT00381472

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
idiopathic parkinson's disease
Descripción

Parkinson Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030567
modified hoehn and yahr scale stages ii - iv
Descripción

UPDRS - Modified Hoehn and Yahr Staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3639878
stable dose of l-dopa for at least 4 weeks prior to screening.
Descripción

Levodopa Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
lack of control with l-dopa therapy.
Descripción

Levodopa | control Lack

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023570
UMLS CUI [2,1]
C0243148
UMLS CUI [2,2]
C0332268
women of child-bearing potential must use a clinically accepted form of birth control.
Descripción

Childbearing Potential Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
significant and/or uncontrolled medical conditions (excluding parkinson's disease) within 3 months of screening.
Descripción

Medical condition Significant | Medical condition Uncontrolled | Parkinson Disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0750502
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0030567
any abnormality, at screening, that is considered clinically relevant by the investigator.
Descripción

Abnormality Relevant Clinical

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1704258
UMLS CUI [1,2]
C2347946
UMLS CUI [1,3]
C0205210
dementia
Descripción

Dementia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0497327
use of dopamine agonists within 4 weeks of screening visit.
Descripción

Dopamine Agonists

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178601
participation in other investigational drug studies.
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230

Similar models

Eligibility Parkinson Disease NCT00381472

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease
Item
idiopathic parkinson's disease
boolean
C0030567 (UMLS CUI [1])
UPDRS - Modified Hoehn and Yahr Staging
Item
modified hoehn and yahr scale stages ii - iv
boolean
C3639878 (UMLS CUI [1])
Levodopa Dose Stable
Item
stable dose of l-dopa for at least 4 weeks prior to screening.
boolean
C0023570 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Levodopa | control Lack
Item
lack of control with l-dopa therapy.
boolean
C0023570 (UMLS CUI [1])
C0243148 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods
Item
women of child-bearing potential must use a clinically accepted form of birth control.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Medical condition Significant | Medical condition Uncontrolled | Parkinson Disease
Item
significant and/or uncontrolled medical conditions (excluding parkinson's disease) within 3 months of screening.
boolean
C3843040 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0030567 (UMLS CUI [3])
Abnormality Relevant Clinical
Item
any abnormality, at screening, that is considered clinically relevant by the investigator.
boolean
C1704258 (UMLS CUI [1,1])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Dementia
Item
dementia
boolean
C0497327 (UMLS CUI [1])
Dopamine Agonists
Item
use of dopamine agonists within 4 weeks of screening visit.
boolean
C0178601 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs
Item
participation in other investigational drug studies.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial